Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 43.35
+0.11 (0.25%)
Apr 29, 2026, 3:00 PM CST
SHA:688363 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 20,684 | 20,895 | 24,416 | 32,239 | 65,081 | 74,544 | Upgrade
|
| Market Cap Growth | -10.59% | -14.42% | -24.27% | -50.46% | -12.69% | 6.06% | Upgrade
|
| Enterprise Value | 20,027 | 20,429 | 24,211 | 31,288 | 63,593 | 73,055 | Upgrade
|
| Last Close Price | 43.24 | 43.68 | 50.93 | 66.39 | 133.30 | 152.44 | Upgrade
|
| PE Ratio | 70.89 | 71.54 | 140.10 | 54.41 | 67.03 | 95.28 | Upgrade
|
| Forward PE | 37.31 | 38.61 | 34.88 | 29.56 | 51.50 | 90.88 | Upgrade
|
| PS Ratio | 4.93 | 4.98 | 4.55 | 5.31 | 10.23 | 15.07 | Upgrade
|
| PB Ratio | 2.91 | 2.94 | 3.57 | 4.62 | 9.74 | 13.07 | Upgrade
|
| P/TBV Ratio | 3.24 | 3.27 | 3.97 | 5.20 | 11.01 | 14.43 | Upgrade
|
| P/FCF Ratio | 68.54 | 69.24 | - | - | - | 151.56 | Upgrade
|
| P/OCF Ratio | 32.97 | 33.30 | 43.25 | 46.08 | 102.46 | 58.42 | Upgrade
|
| PEG Ratio | - | 1.22 | 1.22 | 1.22 | 1.90 | 1.98 | Upgrade
|
| EV/Sales Ratio | 4.77 | 4.87 | 4.51 | 5.15 | 10.00 | 14.77 | Upgrade
|
| EV/EBITDA Ratio | 25.53 | 26.55 | 52.02 | 40.35 | 56.57 | 84.27 | Upgrade
|
| EV/EBIT Ratio | 43.61 | 44.49 | 104.19 | 54.87 | 66.14 | 97.87 | Upgrade
|
| EV/FCF Ratio | 66.36 | 67.70 | - | - | - | 148.53 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.03 | 0.06 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.44 | 0.44 | 0.68 | 0.25 | 0.33 | 0.33 | Upgrade
|
| Debt / FCF Ratio | 1.13 | 1.13 | - | - | - | 0.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.10 | -0.06 | -0.16 | -0.26 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.89 | -0.89 | -0.84 | -1.42 | -1.55 | -2.71 | Upgrade
|
| Net Debt / FCF Ratio | -2.28 | -2.28 | 2.48 | 3.33 | 28.54 | -4.78 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.63 | 0.71 | 0.79 | 0.75 | Upgrade
|
| Inventory Turnover | 1.12 | 1.12 | 1.24 | 1.45 | 1.59 | 1.89 | Upgrade
|
| Quick Ratio | 1.38 | 1.38 | 1.00 | 1.47 | 1.61 | 2.20 | Upgrade
|
| Current Ratio | 2.34 | 2.34 | 2.04 | 2.56 | 2.45 | 2.85 | Upgrade
|
| Return on Equity (ROE) | 4.17% | 4.17% | 2.44% | 8.53% | 15.52% | 14.47% | Upgrade
|
| Return on Assets (ROA) | 3.31% | 3.31% | 1.70% | 4.15% | 7.42% | 7.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.15% | 6.22% | 2.97% | 8.75% | 19.64% | 20.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 6.10% | 3.20% | 7.90% | 13.70% | 12.20% | Upgrade
|
| Earnings Yield | 1.41% | 1.40% | 0.71% | 1.84% | 1.49% | 1.05% | Upgrade
|
| FCF Yield | 1.46% | 1.44% | -0.64% | -1.03% | -0.09% | 0.66% | Upgrade
|
| Dividend Yield | 0.25% | - | 0.22% | 0.57% | 0.46% | 0.32% | Upgrade
|
| Payout Ratio | 19.20% | 19.20% | 106.69% | 51.55% | 25.01% | 25.69% | Upgrade
|
| Buyback Yield / Dilution | 1.09% | 1.09% | -0.48% | 0.27% | -0.03% | -0.95% | Upgrade
|
| Total Shareholder Return | 1.35% | 1.09% | -0.27% | 0.84% | 0.43% | -0.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.